National Institutes of Health
Mukesh Verma is a Program Director and Chief in the Methods and Technologies Branch (MTB), Epidemiology and Genetics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), National Institutes of Health (NIH). Before coming to the DCCPS, he was a Program Director in the Division of Cancer Prevention (DCP), NCI, providing direction in the areas of biomarkers, early detection, risk assessment and prevention of cancer, and cancers associated with infectious agents. Mukesh Verma holds a M.Sc. from Pantnagar University and a Ph.D. from Banaras Hindu University. He did postdoctoral research at George Washington University and was a faculty member at Georgetown University. He has published 125 research articles and reviews and edited four books in cancer epigenetics and epidemiology field. Verma has developed concepts (PA and RFA) on exfoliated cells and circulating DNA and their application in cancer detection and risk assessment, cancer epidemiology, risk prediction models in cancer, mitochondrial DNA and cancer epidemiology, cancer epigenetics, pancreatic cancer etiology, AIDS related malignancies, and systems genetics. Verma represents NCI in NIH Common Funds Metabolomics and NIH Roadmap Epigenomics. He also served as the Project Officer for an Inter Agency Agreement with CDC with focus on biomarkers of cervical cancer.
Cancer epidemiology, risk prediction models in cancer, mitochondrial DNA and cancer epidemiology, cancer epigenetics, pancreatic cancer etiology, AIDS related malignancies, and systems genetics.